APA (7th ed.) Citation

E, V., I, N., D, C., M, D., V, K., K, R., . . . E, T. (2019). Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density. Annals of hematology, 98(7), 1583. https://doi.org/10.1007/s00277-019-03695-x

Chicago Style (17th ed.) Citation

E, Voskaridou, Ntanasis-Stathopoulos I, Christoulas D, Dimopoulou M, Komninaka V, Repa K, Papatheodorou A, and Terpos E. "Activin-A Is Elevated in Patients with Thalassemia Major and Double Heterozygous Sickle Cell/beta-thalassemia and Correlates with Markers of Hemolysis and Bone Mineral Density." Annals of Hematology 98, no. 7 (2019): 1583. https://doi.org/10.1007/s00277-019-03695-x.

MLA (9th ed.) Citation

E, Voskaridou, et al. "Activin-A Is Elevated in Patients with Thalassemia Major and Double Heterozygous Sickle Cell/beta-thalassemia and Correlates with Markers of Hemolysis and Bone Mineral Density." Annals of Hematology, vol. 98, no. 7, 2019, p. 1583, https://doi.org/10.1007/s00277-019-03695-x.